EODData

NASDAQ, AGIO:

02 Sep 2025
LAST:

39.25

CHANGE:
 1.54
OPEN:
38.00
HIGH:
39.37
ASK:
50.20
VOLUME:
630.4K
CHG(%):
4.08
PREV:
37.71
LOW:
37.82
BID:
93.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Sep 2538.0039.3737.8239.25630.4K
29 Aug 2538.3538.7837.3837.71502.7K
28 Aug 2539.2439.5137.9438.18433.1K
27 Aug 2538.3340.1038.3339.27725.1K
26 Aug 2537.4538.5236.9938.46647.3K
25 Aug 2538.8039.1937.1137.26699.6K
22 Aug 2538.2539.6937.7538.80722.5K
21 Aug 2536.7038.4636.4038.20460.8K
20 Aug 2535.9536.9035.9236.82400.6K
19 Aug 2537.4837.7335.9236.22672.1K

COMPANY PROFILE

Name:
About:Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it develops tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and hemolytic anemias; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:88 Sidney Street, Cambridge, MA, United States, 02139
Website:https://www.agios.com
CUSIP:00847X104
CIK:0001439222
ISIN:US00847X1046
FIGI:BBG000QY4ZD0
LEI:529900ONJHY8EOGYT555

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:3.21
Price to Book:1.54
Price to Sales:51.48
Shares:58.1M
Market Cap:2.28B

TECHNICAL INDICATORS

MA5:38.57
MA10:38.02
MA20:37.26
MA50:37.19
MA100:33.93
MA200:35.61
STO9:74.09
STO14:78.09
RSI14:65.44
WPR14:-0.66
MTM14:2.64
ROC14:0.07
ATR:1.51
Week High:40.10
Week Low:36.99
Month High:40.10
Month Low:26.75
Year High:62.58
Year Low:23.42
Volatility:18.89